The Federation of Indian Chamber of Commerce & Industry (FICCI) has suggested a seven-point programme to the government to help the sector generate revenues of $5 billion and to create one million jobs by 2010.

FICCI suggested that tax benefit should be extended to expenditure incurred on clinical trials. The government may also consider providing relief to recognised biotech, pharmaceutical and clinical research companies by giving a blanket permission of up to Rs One crore per annum to import laboratory consumables.

Currently there is lack of technical expertise at airports and ports to handle biological materials. Customs officials may be updated regularly with new policies on issues related to handling of biological materials.